Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.5.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Jun. 25, 2016
Jun. 27, 2015
Cash flows from operating activities:    
Net income $ 51,478 $ 37,410
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 29,286 25,076
Amortization of deferred financing costs 1,164 2,005
Stock-based compensation 6,069 5,970
Excess tax benefits from stock-based awards (4,726) (685)
Deferred income taxes 12,305 6,416
Write-off of deferred financing costs 3,337 537
Loss on sale of property and equipment 788 662
Gain on sale of manufacturing plant (2,544) 0
Other 190 (51)
Change in assets and liabilities (excluding businesses acquired):    
Accounts receivable (13,236) (29,468)
Inventories (5,928) (13,791)
Prepaid expenses and other assets 6,493 (4,824)
Accounts payable (8,027) 1,694
Accrued expenses 14,812 25,733
Other long-term obligations (1,878) (87)
Net cash provided by operating activities 89,583 56,597
Cash flows from investing activities:    
Additions to property and equipment (19,486) (18,160)
Payments to acquire companies, net of cash acquired (68,901) (16,000)
Proceeds from the sale of facility 3,899
Change in restricted cash 1,129 1,693
Proceeds from short-term investments 0 9,997
Investment in short-term investments 0 (17)
Other investing activities (550) (489)
Net cash used in investing activities (83,909) (22,976)
Cash flows from financing activities:    
Repayments of long-term debt (400,230) (50,216)
Proceeds from issuance of long-term debt 400,000 0
Borrowings under revolving line of credit 419,000 312,000
Repayments under revolving line of credit (419,000) (312,000)
Proceeds from issuance of common stock 280 2,148
Repurchase of common stock, including shares surrendered for tax withholding (9,429) (19,021)
Distribution to noncontrolling interest (592) (1,680)
Payment of financing costs (7,560) 0
Excess tax benefits from stock-based awards 4,726 685
Net cash used in financing activities (12,805) (68,084)
Effect of exchange rate changes on cash and cash equivalents (453) (372)
Net decrease in cash and cash equivalents (7,584) (34,835)
Cash and equivalents at beginning of period 47,584 78,676
Cash and equivalents at end of period 40,000 43,841
Supplemental information:    
Cash paid for interest $ 32,440 $ 22,470